Epstein Secrets

tiA Mount Sinai ERNATIONAL PROSTATE SYMPTOM SCORE (IPSS) Chairman 04mt a UMW/ Mahn School a was* at MOM Sina Ph: (212)241-0955 NAME Jeffrey Epstein DATE July 25, 2016 The questionnaire below was developed by the American Urological Association (AUA) to help men evaluate the severity of their sy

was* at MOM Sina Ph: (212)241-0955 NAME Jeffrey Epstein DATE July 25, 2016 The questionnaire below was

chool a was* at MOM Sina Ph: (212)241-0955 NAME Jeffrey Epstein DATE July 25, 2016 The questionnaire be

an 04mt a UMW/ Mahn School a was* at MOM Sina Ph: (212)241-0955 NAME Jeffrey Epstein DATE July 25, 2016 The questionnaire below was developed by the American Urological Association (AUA) to help men evaluate the severity of their symptoms from benign hyperplasia (BHP). This self-administered test can help determine which treatm

09/18/2018 16:38 From: INIMINIM Woodson C. Merrell M Uebfax Page: 1/11 FAX COVER SHEET To: Jeffrey Epstein / Lesley From: Lisa Company: Company: Woodson Merrell MD PLLC Phone: Pages w/cover: 11 Fax: Date: 9/18/2018 Subject: 9-14-18 LABCORP (

/2010 16:30 From: 3477565616 Woodson C. Merrell M Wehfax Page: 2/11 LabCorp Patient Report Specimen ID: 257-480 2371-0 Control ID: FSB31: 43092 EPSTEIN, JEFFREY 9E 71STST NEW YORK W 10021 Acct 31143092 Woodson Merrell 44 E67th St New York NY 10065 Phone Patient Details Specimen Details Phy

30 From: 3477565616 Woodson C. Merrell M Wehfax Page: 2/11 LabCorp Patient Report Specimen ID: 257-480 2371-0 Control ID: FSB31: 43092 EPSTEIN, JEFFREY 9E 71STST NEW YORK W 10021 Acct 31143092 Woodson Merrell 44 E67th St New York NY 10065 Phone Patient Details Specimen Details Physician De

257-S80-2371D Date collected:09/14/2018 1255 Local TESTS RESULT FLAG UNITS REFERENCE INTERVAL LAB TSH Roche ECLIA methodology. According to the American Urological Association, Serum PSA should decrease and remain at undetectable levels after radical prostatectomy. The AUA defines biochemical recurrence as an initial PSA

09/21/2018 10:18 From: Woodson C. Merrel l M Uebfax Page: 1/13 FAX COVER SHEET fo: Jeffrey Epstein / Company: Fax: Date: 9/21/2018 Subject: 9-14-18 LABCORP Lab Results Jeff From: Lisa Company: Woodson Merrell MD PLLC Phone: Pages w/cove

99800 09/21/2018 10:18 From: Woodson C. Merrell M Uebfax Page: 2/13 LabCorp Patient Report ,!me:, i:1 ",r-lbrU-2371-0 Convo! ID: F3 [143092 EPSTEIN, JEFFREY IS: ST NEW YORK NY 10021 Acct 31143092 Woodson Merrell 44E6AhS( New York NY 10065 Phone: Patient Details Specimen Details Physici

9/21/2018 10:18 From: Woodson C. Merrell M Uebfax Page: 2/13 LabCorp Patient Report ,!me:, i:1 ",r-lbrU-2371-0 Convo! ID: F3 [143092 EPSTEIN, JEFFREY IS: ST NEW YORK NY 10021 Acct 31143092 Woodson Merrell 44E6AhS( New York NY 10065 Phone: Patient Details Specimen Details Physician Detail

with diabetes: <7.0 01 Prostate-Specific Ag, Serum Prostate Specific Ag, Serum 0.7 ng/mL 0.0 - 4.0 01 Roche ECLIA methodology. According to the American Urological Association, Serum PSA should decrease and remain at undetectable levels after radical prostatectomy. The AUA defines biochemical recurrence as an initial PSA

s Number 31143092 Account R Number Rowe I 68 Nbmc Um Nnw Epstein Anon Address Woodson Merrell 44 E 67th St New York NY 10065 PaimaimNme Jeffrey PuMwMADeNmx PadeaSP PricaMmac 212-750-9895 TwalVokame ar(Ymm) 63/07/19 Dared Binh 01/20/53 Sex M Fladas Yes Patna Address 9 E 71ST ST

l/L nm - 99 100 - 130 - 160 - 100 129 159 189 189 >39 0 - 149 100 - 199 >=30.5 <=527 >20.5 01 01 01 01 01 01 01 01 01 01 01 Epstein, Jeffrey 09/14/16 10:25 ET DUPLICATE FINAL REPORT This dcaunent contains private and confidential health information protected by slat and feder

ITS REFERENCE INTERVAL LAB Prostate-Specific Ag, Serum Prostate Specific Ag, Serum Roche ECLIA methodology. 0.6 ng/mL 0.0 - 4.0 According to the American Urological Association, Serum PSA should decrease and remain at undetectable levels after radical prostatectomy. The AUA defines biochemical recurrence as an initial PSA

„,...„ Nth ,R., 263-480-2797-0 l'..n: II) II Connol NomIni CNT31143092 Acoand No 31143092 ”I —nnsni Minn< Nun d,r , 212-535-1012 Ho w 70 EPSTEIN mw ifi lddN m , A,,,. n. ..IA.w., Woodson Merrell 44 E 67th St New York NY 10065 I'.“ , r I \,n, JEFFREY l'ancout Allan.: bialvol.m. An-

Nun d,r , 212-535-1012 Ho w 70 EPSTEIN mw ifi lddN m , A,,,. n. ..IA.w., Woodson Merrell 44 E 67th St New York NY 10065 I'.“ , r I \,n, JEFFREY l'ancout Allan.: bialvol.m. An- 01101), 60/08/00 ItncAndth 01/20/53 'w ii M laginr. I'dficni Atkin:, 9 E 71ST ST NEW YORK NY 10065 Addi

tes: <7.0 Prostate-Specific Ag, Serum Prostate Specific Ag, Serum Roche ECLIA methodology. 0.8 ng/mL 4.8 - 5.6 02 0.0 - 4.0 02 According to the American Urological Association, Serum PSA should decrease and remain at undetectable levels after radical prostatectomy. The AUA defines biochemical recurrence as an initial PSA

ethods or kits cannot be used interchangeably. Results cannot be interpreted as absolute evidence of the presence or absence of malignant disease. EPSTEIN, JEFFREY 294-142-382B-0 Seq 12713 10/26/10 10:17 ET DUPLICATE FINAL REPORT Ths d0CIAINIX COO Win pave Le and confideanal health infoonatIon poth

kits cannot be used interchangeably. Results cannot be interpreted as absolute evidence of the presence or absence of malignant disease. EPSTEIN, JEFFREY 294-142-382B-0 Seq 12713 10/26/10 10:17 ET DUPLICATE FINAL REPORT Ths d0CIAINIX COO Win pave Le and confideanal health infoonatIon pothered by s

result with this method. Prostate—Specific Ag, Serum Prostate Specific Ag, Serum 0.7 ng/mL 0.0 - 4.0 01 Roche ECLIA methodology. According to the American Urological Association, Serum PSA should decrease and remain at undetectable levels after radical prostatectomy. The AUA defines biochemical recurrence as an initial PSA